Related Experiment Videos

p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases

X L Quian1, S J Decker, M I Greene

  • 1Department of Biology, University of Pennsylvania, School of Medicine, Philadelphia 19104-6082.

Insights

The neu protooncogene protein (p185c-neu) and epidermal growth factor receptor (EGFR) form a heterodimer. This complex formation, driven by noncovalent bonds and EGF binding, enhances protein kinase activity, impacting cell transformation and tumorigenicity.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • p185c-neu and EGFR are receptor tyrosine kinases.
  • Overexpression of both, not individually, causes transformation and tumorigenicity.
  • M1 cells express both p185c-neu and EGFR, enabling heterodimerization.

Purpose of the Study:

  • To investigate the heterodimerization of p185c-neu and EGFR.
  • To determine the nature of the association between these receptors.
  • To elucidate the functional and enzymatic properties of the EGFR-p185c-neu heterodimer.

Main Methods:

  • Analysis of receptor association using nondenaturing detergents.
  • Investigating the role of epidermal growth factor (EGF) binding.
  • Assessing protein kinase activity and phosphorylation status in vitro and in vivo.

Main Results:

  • p185c-neu and EGFR form a heterodimer through noncovalent interactions.
  • EGF binding promotes rapid, reversible heterodimerization.
  • The heterodimer exhibits high protein kinase activity, including autophosphorylation and substrate phosphorylation.
  • The heterodimer is highly tyrosine-phosphorylated in vivo.

Conclusions:

  • Physical association between EGFR and p185c-neu is functionally significant.
  • Heterodimer formation enhances receptor tyrosine kinase activity.
  • This complex formation plays a role in cell transformation and tumorigenicity.

Related Concept Videos